Speakers - San Francisco Symposium 2018
Donogh O'Mahony joined Nektar Therapeutics in 2011, where he is a Staff Scientist; currently he divides his time between new chemical entity design and synthesis, and leading the implementation effort of the Dotmatics suite within discovery research. Prior to this he worked on anti-infectives at NovaBay Pharmaceuticals, and CNS indications at Renovis (acquired by Evotec). He received his fist introduction to the power of cheminformatics solutions in 1999 upon joining SIDDCO (acquired by Discovery Partners Int’l, Inc.) where he worked in chemical library synthesis. Donogh completed BSc and PhD degrees at Imperial College London, and conducted further postdoctoral research at Montana State University Bozeman.
Research Associate II - Chemistry
Katherine studied chemistry at Wesleyan University in Middletown, Connecticut and has been working at DiCE Molecules since she graduated. In her role at DiCE, she is focused on chemistry development for DNA encoded libraries. She has also been heavily involved in the implementation of Dotmatics and testing of custom Dotmatics solutions at DiCE.